Correlation Between Cingulate Warrants and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Monopar Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Monopar Therapeutics.
Diversification Opportunities for Cingulate Warrants and Monopar Therapeutics
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cingulate and Monopar is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Monopar Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 3.6 times more return on investment than Monopar Therapeutics. However, Cingulate Warrants is 3.6 times more volatile than Monopar Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.08 per unit of risk. If you would invest 6.00 in Cingulate Warrants on August 24, 2024 and sell it today you would lose (2.23) from holding Cingulate Warrants or give up 37.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 75.2% |
| Values | Daily Returns |
Cingulate Warrants vs. Monopar Therapeutics
Performance |
| Timeline |
| Cingulate Warrants |
| Monopar Therapeutics |
Cingulate Warrants and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Monopar Therapeutics
The main advantage of trading using opposite Cingulate Warrants and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Cingulate Warrants vs. Lyra Therapeutics | Cingulate Warrants vs. Hookipa Pharma | Cingulate Warrants vs. SAB Biotherapeutics | Cingulate Warrants vs. Cadrenal Therapeutics, Common |
| Monopar Therapeutics vs. Lyra Therapeutics | Monopar Therapeutics vs. Hookipa Pharma | Monopar Therapeutics vs. Cingulate Warrants | Monopar Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |